tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB

Compare Biogen (BIIB) vs. Competitors

5,003 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Biogen
$172.97
$25.38B
19.96
52.56%
11 Buy
14 Hold
1 Sell
Moderate Buy
Amgen
$351.02
$189.22B
22.84
24.74%
12 Buy
11 Hold
1 Sell
Moderate Buy
Bristol-Myers Squibb
$58.62
$119.69B
15.61
16.17%
8 Buy
12 Hold
1 Sell
Moderate Buy
Gilead Sciences
$138.99
$176.37B
17.94
37.07%
17 Buy
5 Hold
0 Sell
Strong Buy
GlaxoSmithKline
$58.21
$116.98B
13.19
73.24%
0 Buy
3 Hold
0 Sell
Hold
AbbVie
$207.94
$367.80B
96.82
19.37%
15 Buy
7 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BIIB
Biogen
172.97
53.71
45.04%
AMGN
Amgen
351.02
66.04
23.17%
BMY
Bristol-Myers Squibb
58.62
9.72
19.89%
GILD
Gilead Sciences
138.99
35.25
33.98%
GSK
GlaxoSmithKline
58.21
24.28
71.56%
ABBV
AbbVie
207.94
34.65
20.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts